Oral solid composition containing ibandronic acid or its pharmaceutically acceptable salts and vitamin D

摘要

The invention relates to an improved solid pharmaceutical composition for oral administration, comprising ibandronic acid or a pharmaceutically acceptable salt thereof. Vitamin D and medium chain glycerin or partially hydrogenated oils provide the physicochemical properties needed for solid oral preparations suitable for the treatment of bone diseases and calcium metabolism disorders.